Author Index

Arthritis & Rheumatism, Volume 63,
November 2011 Abstract Supplement

Abstracts of the American College of
Rheumatology/Association of Rheumatology Health Professionals
Annual Scientific Meeting
Chicago, Illinois November 4-9, 2011.

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


UBC 2011 MPT Students A Survey of Physical Therapists' Use of Outcome Measures In Total Hip and Knee Arthroplasty.
Ubeda* CarlesA Distinctive Oral Microbiome Characterizes Periodontitis in Patients with Early Rheumatoid Arthritis.
Uchida AtsumasaPrevention of Celecoxib Induced Gastrointestinal Events by Concomitant Therapy with Rebamipide, Gastro-Protective Drug.
Uchimura ShoichiSNP Algorithms for Prediction of Efficacy and Adverse Events of Abatacept.
Uchino AyumiSome of Subgroups in Rheumatoid Arthritis Are Difficult to Differentiate with Polymyalgia Rheumatica by a Genome-Wide Gene Expression Analysis.
Uda HiroshiHigh Levels of Serum IL-6 but Not CRP or TNF- During Tocilizumab Treatment Induces Myalgia Among the Patients with Rheumatoid Arthritis.
Udata ChandrasekharPharmacokinetic-Pharmacodynamic Modeling of Ozoralizumab (ATN-103), a Novel Humanized Nanobody Tumor Necrosis Factor Inhibitor for Rheumatoid Arthritis.
 A Multiple Ascending Dose/Proof of Concept Study of ATN-103 (ozoralizumab) in Rheumatoid Arthritis Subjects on a Background of Methotrexate.
Ueda AtsuhisaBach1 Regulates Osteoclastogenesis Via Heme Oxgenase-1 Dependent and Independent Pathways.
 Ultrasonography Is a Potent Tool for Prediction of Ongoing Joint Destruction During Clinical Remission of Rheumatoid Arthritis.
 Treatment with Infliximab Is Effective and Safty in BD Patients with Uveitis.
Uehara TakeakiTreatment with Infliximab Is Effective and Safty in BD Patients with Uveitis.
 Ultrasonography Is a Potent Tool for Prediction of Ongoing Joint Destruction During Clinical Remission of Rheumatoid Arthritis.
Ueki NaokoInduction of Regulatory B Cells in Healthy Individuals and Patients with Systemic Lupus Erythematosus.
Ueki UkitakaRemission Induction by Etanercept (ETN) Plus Methotrexate (MTX) Combination Therapy Versus ETN Monotherapy in Patients with Active Rheumatoid Arthritis Despite MTX Treatment.
Ueki YasuyoshiSH3BP2 Cherubism Gain-of-Function Mutation Exacerbates Inflammation and Bone Erosion in Collagen Induced Arthritis.
Ueland ThorMonocyte Chemoattractant Protein-1 and Pentraxin in Systemic Lupus Erythematosus.
Uesato RyokoTreating to Target Matrix Metalloproteinase 3 Normalisation Together with Disease Activity Score Below 2.6 Yields Better Effects Than Each Alone In Rheumatoid Arthritis Patients: Treating to Twin Targets; T-4 Study.
Uetani MasatakaEvaluation of the Patients with Early Arthritis by 2010 RA Criteria in Conjunction with MRI of Wrists and Finger Joints.
Ughi NicolaShock Wave Therapy: A Novel Treatment for Systemic Sclerosis?
 Acute-Phase Response After Zoledronic Acid: Role of Vitamin D and of Previous Treatment with Oral Amino-Bisphosphonates.
Ugurlu SerdalDO Carriers of A MEFV Mutation Have Any Selective Advantage to A Pathogen Endemic In the Same Geography?
 Four Novel MEFV Gene Mutations in a Population Where the Prevalence of Crimean-Congo Hemorrhagic Fever and MEFV Gene Carrier Status Is Very High.
 Some Manifestations Disappear Earlier Than Others in Behcet's Syndrome.
Uhlig TillDifferent Remission Definitions Capture Different Proportions of Patients with Rheumatoid Arthritis Treated in Clinical Practice.
 Disease Impact of Osteoarthritis in Hands, Hip, Knee or Generalized Osteoarthritisa Cross Sectional Study.
 Rheumatoid Arthritis Continues to Improve in the New Millennium Whilst Use of Medication Change. Findings From a Representative Rheumatoid Arthritis Register Over 15 Years.
Uhm Wan-sikWhat Factors Affect Discordance Between Physicians and Patients in Assessments of Global Health in Rheumatoid Arthritis?
 Do Patients with Elderly-Onset Rheumatoid Arthritis Have Severe Functional Disability?
Ullmann MartinPharmacokinetics of IV Abatacept in Systemic Lupus Erythematosus Patients with Active Proliferative Glomerulonephritis.
Ullrich SebastianCD15s Expression Pattern in the Synovial Tissue of Patients with Rheumatoid Arthritis and Its Role in RASF Migration.
 Perspective on Hypoxic Signalling in Granulomatosis with Polyangiitis (Wegener's)Increased Expression of HIF-1 and Glut-1 in Granulomatous Lesions of the Nasal Cavity.
Ulmansky RinaA Humanized Monoclonal Antibody Against a Surface Ligand of Mononuclear Cells Suppress Autoimmune Inflammatory Diseases by Upregulation of IL-10 Secretion.
Ulph FionaInvestigating children's beliefs about Juvenile Arthritis: A Study Using Cognitive Interviewing.
Ulug AzizCognitive Dysfunction and Diffusion Tensor Imaging in Systemic Lupus Erythematosus.
 Cognitive Differences in Systemic Lupus Erythematosus Patients From the Western (Denver, CO) and Eastern (New York, NY) Regions of the United States.
Umeda NaotoIL-6 Overproduction Is Predominantly Related to Arthritis in TNF-Induced Adipose-Related Protein (TIARP) Deficient Mice.
 Evaluation of Activity, Making Diagnosis and Prediction of Future Bone Destruction by Using Low Field Compact Magnetic Resonance Imaging Machine in Patients with Rheumatoid Arthritis.
Umicevic-Mirkov MashaGenome-Wide Association Analysis of Rheumatoid Arthritis Patients Treated with Anti-TNF Medication.
Ummenhofer KatharinaEarly Recognition of Hearing Loss in Muckle-Wells Syndrome.
Undeutsch ReinmarSystemic Sclerosis As Prototypic Disease for Functional Antibodies Against Vascular Receptors: From Beside to Bench and Mouse Models.
Univ of Maryland Schl of Med Inpatient Mortality Related to Cerebrovascular Disease in Systemic Lupus Erythematosus: The Impact of Delay in Diagnosis of Neuropsychiatric Lupus.
Unizony SebastianRituximab for the Treatment of IgG4-Related Disease:Lessons From Ten Consecutive Patients.
 Tocilizumab for the Treatment of Large Vessel Vasculitis (Giant Cell Arteritis, Takayasu Arteritis) and Polymyalgia Rheumatica: A Case Series.
Unnebrink KristinaSafety and Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis During More Than 5 Years of Therapy Observed in a Phase 3b and Post-Marketing Observational Study.
Unni SudhirSerum Uric Acid Testing Patterns In Gout Patients: A Need for Improved Monitoring.
Uno KiyokoAtherosclerotic Burden In Patients with Psoriatic Arthritis and Psoriasis: Do They Differ?
 Cardio-Metabolic Risk Profile of Patients with Psoriatic Arthritis and Psoriasis.
Urata YukitomoTreating to Target Matrix Metalloproteinase 3 Normalisation Together with Disease Activity Score Below 2.6 Yields Better Effects Than Each Alone In Rheumatoid Arthritis Patients: Treating to Twin Targets; T-4 Study.
Urbonaviciute VilmaEfficient Depletion of Autoreactive Plasma Cells within the Nephritic Kidneys in a Murine Model of SLE by Bortezomib.
Urcelay ElenaMechanisms Underlying the Generation of Soluble IL-6 Soluble Receptor (sIL-6R) in Rheumatoid Arthritis: mRNA Alternative Splicing and Proteolytic Cleavage As Independent Contributors.
Urena InmaculadaApplication of Combined Algorithms with Peripheral Bone Mineral Density (BMD) and Risk Indeces to Reduce the Requirement for Central Dual X-Ray Absorptometry (DXA).
Uriarte-Isacelaya EstherThe Lupus Damage Index Questionnaire and Its Correlation with the SLICC/ACR Damage Index and the LupusQoL in a Spanish Multicenter Lupus Cohort. Is It Really Measuring Damage?
Uribe AmericaParents' Attitudes towards Research and Research Study Participation in Pediatric Rheumatology (PR).
Urien SaikEvidence for a Direct Role of Anti-Signal Recognition Particle Antibodies in the Pathogenesis of Necrotizing Myopathies.
Urita YoshihisaEvaluation of 13c-Acetate Plus Lactulose Breath Test, a New Examination to Measure Intestinal Absorption in Patients with Systemic Sclerosis.
Urowitz Murray B.Lupus Disease Activity Does Not Improve Significantly in One System and Worsen in Another System.
 Frequency and Characteristics of Prolonged Remission in Systemic Lupus Erythematosus.
 High-Sensitivity C-Reactive Protein As An Independent Risk Factor for Coronary Artery Disease in Systemic Lupus Erythematosus.
 A Risk Management Program Led by a Nurse Improves Cardiovascular and Osteoporosis Risk Management in a Specialized Lupus Clinic.
 Retrospective Validation of the 3 Laboratory Organ Systems of Systemic Lupus Erythematosus Disease Activity Index-2000 (SLEDAI-2K) Responder Index (SRI-50) Over 10 Years.
 Anti-C1q Antibody in Systemic Lupus Erythematosus.
 Electrocardiographic Abnormalities in a Large Systemic Lupus Erythematosus Inception Cohort.
 Development of Atherosclerotic Vascular Events in Systemic Lupus Erythematosus: How Important Are Race/Ethnicity and Geography?
 Quality of Life Measures Are Not Associated and Have No Discriminative Validity in Lupus Patients for Different Levels of Disease Activity.
 Predictors of Seizures in Systemic Lupus Erythematosus.
 Time to Recovery From Proteinuria in Lupus Nephritis Patients Receiving Standard of Care Treatment.
 Do Race/Ethnicity and Geography Affect Outcomes in An Inception Cohort of Patients with Systemic Lupus Erythematosus Followed for at Least 5 Years?
 Clinical-Pathological Correlates of Proliferative Lesions in Lupus Nephritis.
 Treatment of Hypertension and Hypercholesterolemia Is Not Successful in the Majority of Patients with Systemic Lupus Erythematosus.
 Late Versus Early Development of Lupus Nephritis.
 Clinical Impact of Frequency of Visits in Systemic Lupus Erythematosus.
 Adjusted Framingham Risk Factor Scoring for Systemic Lupus Erythematosus.
 Anti-Nucleosome Antibodies Correlate with Temporal Fluctuations in Disease Activity in Systemic Lupus Erythematosus.
 Hospitalization in Patients with Systemic Lupus Erythematosus.
 Anti-beta2 Glycoprotein I IgA in Systemic Lupus Erythematosus Versus Controls.
 A Prospective Study of Seizures in Systemic Lupus Erythematosus.
 Altered Selection Leads to Expansion of the Anergic IgM B Cell Population in SLE.
 Derivation and Validation of Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus.
 Prevalence of Direct Coombs Test in Systemic Lupus Erythematosus. Clinical and Immunologic Associations.
 Do Active Lupus Patients Continue to Improve At 12 Months by Systemic Lupus Erythematous Disease Activity Index 2000 Responder Index 50 (SRI-50)?
Urquhart AndrewPsychological Predictors of Failure to Improve After Lower Extremity Joint Arthroplasty.
Urresola AranzazuValidation of the Measurement of Tophi with Magnetic Resonance Imaging As An Outcome Measure for Chronic Gout.
Urwin CraigPregabalin Reduces Posterior Insula Combined Glutamate and Glutamine in Fibromyalgia.
Usategui AliciaTranscriptome Analysis Reveals a Robust Profile In Osteoarthritis Synovial Fibroblasts.
 Thymic Stromal Lymphopoietin (TSLP) Is Overexpressed in Scleroderma Skin and It Is Induced by TLR3 Activation in Dermal Fibroblasts.
 Topical Vitamin D Analogue Calcipotriol Superinduces TSLP and IL-13 Expression in the Bleomycin Scleroderma Model but Does Not Modify Fibrosis.
Ustek DuranGenome-Wide Analysis of Imputed Genotypes Identifies Chemokine Receptor-1 CCR1) As a Novel Candidate Risk Locus in Behet's Disease.
 An Insertion Mutation in the MDFIC (MyoD Family Inhibitor Domain Containing) Gene Defines a Novel Autoinflammatory Syndrome Associated with Lymphedema.
Ustianowski AndrewOpportunistic Infections in Patients Exposed to Anti-Tumour Necrosis Factor Therapy: Results From the British Society for Rheumatology Biologics Register.
Usuda HiroyukiAnti-Inflammatory Profile of AS2444697, A Novel Interleukin-1 Receptor-Associated Kinase-4 Inhibitor.
Usui TakashiClinical Features and Treatment of Dermatomyositis Patients with Anti-CADM-140 (melanoma differentiation-associated protein 5: MDA5) Antibody; Recommendation of Combined Immunosuppressive Therapy with Intensive Intravenous Cyclophosphamide.
Utani AtsushiThe Effect of Trichostatin A, One of the Histone Deacetylase Inhibitor, on Skin Fibrosis Mouse Model.
Uto KenichiThe De Novo Revision of TCR but Not TCR Is Responsible for the Generation of Autoantibody-Inducing CD4 (ai CD4) T Cell That Causes Systemic Autoimmunity.
Utset Tammy O.Racial Disparities In Treatment Preferences Among Lupus Patients In An Urban Academic Center.
 The Effects of Smoking on Age of Onset, Autoantibodies and Interferon- in Systemic Lupus Erythematosus.
Utsunomiya MasakoTocilizumab and Tumor Necrosis Factor Inhibitors in Biologic Switchers: Similar Drug Survival and Safety with Different Infection Profile in Routine Practice.
 Difference of Manifestations and Treatment Among Behcet's Syndrome Patients in the United States and Japan.
Uzunhan YurdagulThe Clinical Spectrum but Not the Evolution of Antisynthetase Syndrome Is Related to the Antisynthetase Antibody Specificity: A Retrospective Analysis of 142 Patients.
Abstract Supplement

Meeting Menu